Profile
Mark A. Longer worked as a Senior Director-Regulatory Affairs at Amylin Pharmaceuticals, Inc. from 2007 to 2013.
He then worked as an Executive Director-Regulatory Affairs at Ardea Biosciences, Inc. from 2013 to 2015.
After that, he worked as a VP-Regulatory Affairs & Quality Assurance at Mast Therapeutics, Inc. He also worked as a VP-Program Planning & Management at Napo Pharmaceuticals, Inc. from 2006 to 2007.
Dr. Longer holds a doctorate degree from the University of Wisconsin and an undergraduate degree from The College of Wooster.
Former positions of Mark Longer
| Companies | Position | End |
|---|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | General Counsel | 31/01/2015 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | General Counsel | 31/12/2012 |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Corporate Officer/Principal | 31/07/2007 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | General Counsel | - |
Training of Mark Longer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
The College of Wooster
The College of Wooster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Mark Longer
















